<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T10:06:55Z</responseDate>
  <request identifier="oai:figshare.com:article/34026974" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34026974</identifier>
        <datestamp>2026-09-29T17:39:11Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Aligned intrinsic disorder profiles of the S100 proteins capable of interaction with the TNFSF members (A) and of the non-interacting S100 proteins (B).&lt;/p&gt;</dc:title>
          <dc:creator>Victoria A. Rastrygina (25138459)</dc:creator>
          <dc:creator>Evgenia I. Deryusheva (7300229)</dc:creator>
          <dc:creator>Alexey S. Kazakov (6178109)</dc:creator>
          <dc:creator>Andrey S. Sokolov (25138462)</dc:creator>
          <dc:creator>Maria E. Permyakova (25138465)</dc:creator>
          <dc:creator>Ekaterina A. Litus (25138468)</dc:creator>
          <dc:creator>Vladimir N. Uversky (123421)</dc:creator>
          <dc:creator>Eugene A. Permyakov (13802061)</dc:creator>
          <dc:creator>Sergei E. Permyakov (13802058)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>s100p evidences involvement</dc:subject>
          <dc:subject>equilibrium dissociation constants</dc:subject>
          <dc:subject>cellular communication mediated</dc:subject>
          <dc:subject>4 − 1bbl</dc:subject>
          <dc:subject>comprises 20 members</dc:subject>
          <dc:subject>treat several autoimmune</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>conserved binding sites</dc:subject>
          <dc:subject>tnfsf members tnf</dc:subject>
          <dc:subject>13 tnfsf members</dc:subject>
          <dc:subject>tnfsf members</dc:subject>
          <dc:subject>used clinically</dc:subject>
          <dc:subject>thereby suppressing</dc:subject>
          <dc:subject>targeting signaling</dc:subject>
          <dc:subject>targeted therapy</dc:subject>
          <dc:subject>soluble forms</dc:subject>
          <dc:subject>s100 proteins</dc:subject>
          <dc:subject>s100 family</dc:subject>
          <dc:subject>potentially important</dc:subject>
          <dc:subject>pleiotropic calcium</dc:subject>
          <dc:subject>p proteins</dc:subject>
          <dc:subject>interaction partners</dc:subject>
          <dc:subject>f89 residue</dc:subject>
          <dc:subject>explored selectivity</dc:subject>
          <dc:subject>cognate receptors</dc:subject>
          <dc:subject>clinical trials</dc:subject>
          <dc:subject>cell proliferation</dc:subject>
          <dc:subject>calcium leads</dc:subject>
          <dc:subject>bone loss</dc:subject>
          <dc:subject>binding proteins</dc:subject>
          <dc:subject>adaptive immunity</dc:subject>
          <dc:subject>24 μm</dc:subject>
          <dc:subject>21 non</dc:subject>
          <dc:subject>2 nm</dc:subject>
          <dc:description>&lt;p&gt;Aligned intrinsic disorder profiles of the S100 proteins capable of interaction with the TNFSF members (A) and of the non-interacting S100 proteins (B).&lt;/p&gt;</dc:description>
          <dc:date>2026-09-29T17:38:55Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.pone.0341400.g010</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_Aligned_intrinsic_disorder_profiles_of_the_S100_proteins_capable_of_interaction_with_the_TNFSF_members_A_and_of_the_non-interacting_S100_proteins_B_p_/34026974</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
